Please enable JS

DISCOVER

Managed Access Programmes

Our technological innovation platform called “CleanWeb-MAP” (CleanWeb Managed Access Programme) facilitates access to new drugs by eligible patients.

There are multiple terms that fall under the umbrella of MAP, including Compassionate Use, Early Access, Named Patient Use and Individual Patient Request Programmes to name but a few. The terms used may vary from country to country depending on local laws and regulations. Our module is closely linked to our CleanWeb software platform for medical data collection, it enables self-registration of prescribing physicians and pharmacists, for each new product related to MAP.

corner top

Ethical and compliant
mechanism of access to drugs

• MAPs provide alternative treatments to patients with life-threatening diseases with no therapeutic options
• CleanWeb-MAP meets local laws and regulations Seamless Managed Access Programmes

corner bottom

Entrust your project
to our expert
data management team

corner top

Drug use outcome
in a real-world setting

Allows you to gain valuable early experience with a product

CleanWeb-MAP facilitates the management of MAPs in real-life conditions

corner bottom

CleanWeb-MAP:
streamlined interactions with stakeholders

Each role and access are clearly defined Physicians, Nurses, Medical Advisor, Programme Manager, Pharmacovigilance officer, Logistics perfectly interact in the MAP cycle process.
The ordering process and the availability of drugs are assured in interaction with any external system and data source.
CleanWeb-MAP allows for the involvement of other stakeholders and for the integration of many additional behaviours (e.g., Pharmacist).

Download our Flyer on MAPs

Do you want to learn more about our e-health solution?
Just fill in the form and we will get back to you shortly

A LEADING POSITION AND
AN INTERNATIONAL DEPLOYMENT

64 +

countries
involved

20 000 +

investigational
Centres

3 million +

patients
in database

50 000 +

users
worlwide

telemedicine technologies earth

LATEST NEWSOUR NEWS >

telemedecine technologies news

Electronic Signatures in Clinical Trials – EUCROF Webinar

September 18, 2025

September 25 – 11am – 12:30pm CEST •The meeting will start at 11.00AM o’clock.•Audio is available either through your computer or through phone connection (dial-in).•Your line will be kept on mute.•At the end, there will be time for questions and you can submit your questionsthrough the ‘question’ box.•After the webinar, connect to the EUCROF eLearnIN […]

READ MORE
telemedecine technologies news

Telemedicine Technologies at BioWin Days 2025

September 18, 2025

September 23 – Namur, Belgium – Booths 26–27 Welcome to BioWin Day ! The premiere venue for doing business with Belgian health professionals, innovators and industry leaders. Explore new partnerships, see what’s evolving in biopharma and health-tech, and get a clear view of how a country as small as Belgium produces world-changing healthcare solutions. What […]

READ MORE
telemedecine technologies news

PDA 2025: Leveraging AI for GxP Compliance in Drug Production

September 18, 2025

Biopharm International The bio/pharmaceutical industry is undergoing a significant digital shift, with artificial intelligence (AI) playing an increasingly vital role in achieving operational excellence and bolstering quality maturity. A strategic and well-governed approach to AI adoption is not merely an advantage but a necessity for enhancing efficiency while maintaining rigorous good practices (GxP) compliance, said […]

READ MORE